tiprankstipranks
Trending News
More News >
IN8bio (INAB)
NASDAQ:INAB

Compare IN8bio (INAB) vs. Competitors

Compare
448 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
IN8bio
$2.59
$12.00M
-0.39
-70.89%
2 Buy
0 Hold
0 Sell
Moderate Buy
Eterna Therapeutics
$1.21
$9.50M
-0.25
-82.03%
Quoin Pharmaceuticals
$11.72
$6.04M
-0.02
-50.23%
1 Buy
0 Hold
0 Sell
Moderate Buy
Xenetic Biosciences
$2.21
$5.54M
-1.18
-43.19%
VYNE Therapeutics
$0.57
$18.87M
-0.72
-78.06%
1 Buy
1 Hold
0 Sell
Moderate Buy
Aprea Therapeutics
$0.89
$6.22M
-0.42
-76.23%
2 Buy
0 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
INAB
IN8bio
2.59
-5.99
-69.81%
ERNA
Eterna Therapeutics
1.21
-5.82
-82.79%
QNRX
Quoin Pharmaceuticals
10.27
-11.22
-52.21%
XBIO
Xenetic Biosciences
2.42
-1.90
-44.07%
VYNE
VYNE Therapeutics
0.57
-2.20
-79.57%
APRE
Aprea Therapeutics
0.89
-3.16
-78.02%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts